e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Tuberculosis and HIV co-infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
P. Tabarsi, E. Chitsaz, A. Moradi, P. Baghai, M. Marjani, M. Masjedi (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2009 - Tuberculosis and HIV co-infection
Session:
Tuberculosis and HIV co-infection
Session type:
E-Communication Session
Number:
3314
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Tabarsi, E. Chitsaz, A. Moradi, P. Baghai, M. Marjani, M. Masjedi (Tehran, Islamic Republic Of Iran). First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran. Eur Respir J 2009; 34: Suppl. 53, 3314
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Investigating trends in antituberculosis (anti-TB) drug resistance among treated patients of a university respiratory infections unit in Greece
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Pattern of second line drug-resistance in MDR-TB treatment failure cases at a tertiary care tuberculosis treatment centre in western region of India
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB
Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis
Year: 2007
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Incidence of TB latent infection in health care workers in a low TB prevalence country
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy
Source: Eur Respir J 2004; 24: 11-17
Year: 2004
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India.
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
The association between HIV and antituberculosis drug resistance
Source: Eur Respir J 2008; 32: 718-725
Year: 2008
TB and drug-resistant TB report from a referral TB unit of Athens. The impact of immigration during the years 1995–2000
Source: Annual Congress 2003 - The various appearance of resistance
Year: 2003
Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Is prevalence of MDR TB and XDR TB decreasing in a tertiary care hospital in India?
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey
Source: Eur Respir J, 51 (3) 1702571; 10.1183/13993003.02571-2017
Year: 2018
HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
The influence of a TB ward in a high TB incidence Romanian area
Source: Eur Respir J 2005; 26: Suppl. 49, 198s
Year: 2005
Resistance pattern to WHO category IV anti tuberculous drugs in patients suspected of multidrug resistance tuberculosis presenting to a specialist clinic in Maharashtra, India
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept